[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Sidekick Health\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":45},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":27,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":5},"100592132",false,"NCT06989450","Digital Patient Support Program for Self-efficacy and Medication Adherence in Women on Adjuvant Endocrine Treatment for Breast Cancer","Digital Patient Support Program for Self-Efficacy and Medication Adherence Amongst Women on Adjuvant Endocrine Treatment for Breast Cancer: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Adult patient (18 years or older) diagnosed with breast cancer of stage I, II or III from 1st September 2023 or later\n* Have been prescribed adjuvant endocrine therapy for breast cancer.\n* Understands written and spoken Icelandic or English.\n* Owns a smart-phone compatible with the Sidekick app and capable to use it\n* Willing to download the Sidekick app on the smart-phone and to comply with the study measures and visits according to the protocol.\n* Capable of providing informed consent for participating in the study.\n\nExclusion Criteria:\n\n* Having other concurrent conditions that in the opinion of the oncologist may compromise patient safety or study objectives.\n* Concurrent participation in another clinical study in which the study treatment may confound the evaluation of the investigational program.\n* Metastatic breast cancer (stage IV)\n* Previous experience with Sidekick breast cancer program","FEMALE","18 Years",{"count":18,"type":19},140,"ESTIMATED","INTERVENTIONAL",[22],"NA","This is a randomized, controlled study to assess the effect of Sidekick Health's digital program on self-efficacy and medication adherence in breast cancer patients prescribed adjuvant anti-hormonal treatment. Participants will be treated with the digital program in addition to standard of care (SoC), or SoC only.",[25,26],"Breast Cancer","Cancer",[26,25,28,29,30,31,32],"Medication adherence","self-efficacy","lifestyle change","endocrine treatment","digital health application","RECRUITING","2025-05-16",{"date":36,"type":37},"2025-05-25","ACTUAL",{"date":39,"type":19},"2025-05-31",{"date":41,"type":19},"2026-12-30",{"name":43,"class":44},"Sidekick Health","INDUSTRY",""]